Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction ; volume:24 ; number:1 ; day:11 ; month:5 ; year:2024 ; pages:1-7 ; date:12.2024
BMC cardiovascular disorders ; 24, Heft 1 (11.5.2024), 1-7, 12.2024
- Creator
-
Cordwin, David J.
Guidi, Jessica
Alhashimi, Lana
Hummel, Scott L.
Koelling, Todd M.
Dorsch, Michael P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-024-03911-1
- URN
-
urn:nbn:de:101:1-2407221024376.170156352069
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cordwin, David J.
- Guidi, Jessica
- Alhashimi, Lana
- Hummel, Scott L.
- Koelling, Todd M.
- Dorsch, Michael P.
- SpringerLink (Online service)
Other Objects (12)
Right ventricular ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance
Animal models of heart failure with preserved ejection fraction
Right ventricular ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance
Animal models of heart failure with preserved ejection fraction
Right ventricular ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction
Vericiguat for Heart Failure with Reduced Ejection Fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance